Columnist Halsey Blocher, who lives with SMA, feels a sense of connection with a Christmas movie's depiction of a disabled princess.

Nearly 4 of every 5 infants in Italy born with SMA type 1 since the approval of disease-modifying therapies (DMTs) are alive, ...

Columnist Ari Anderson has set a goal for 2025: to multiply the chances of good things coming his way each time they happen.

Natalie Katz, MD, is an assistant professor of pediatrics in the division of neurology at Duke University and co-directs the Duke Children’s Neuromuscular Program, which provides comprehensive ...

Edward Smith, MD, is an adjunct professor of pediatrics at Duke University Hospital. He earned his medical degree from the University of Mississippi School of Medicine and has practiced since 2007. He ...

An algorithm may help predict the risk of scoliosis in patients who have received disease-modifying SMA treatment, a study ...

Spinal muscular atrophy (SMA) is a genetic, progressive disease that affects the nervous system and muscles. The life expectancy for people with SMA depends on the type of their disease and symptom ...

Spinal muscular atrophy (SMA) is a rare genetic condition resulting in symptoms that most commonly include progressive muscle weakness and poor muscle tone. While motor function is typically most ...

Due to the progressive nature of spinal muscular atrophy (SMA) — a rare genetic disease — an early diagnosis is critical. People with SMA who receive a timely diagnosis can start treatment immediately ...